Michelle M. Nuño

发表

Alternative Sampling Designs for Time-to-Event Data With Applications to Biomarker Discovery in Alzheimer's Disease

Daniel L. Gillen, Michelle M. Nuño, D. Gillen, 2017 .

More than skin deep: Major histocompatibility complex (MHC)-based attraction among Asian American speed-daters

Michelle M. Nuño, R. Moyzis, Zhaoxia Yu, 2018, Evolution and Human Behavior.

Circulating MicroRNAs for Detection of Germ Cell Tumours: A Narrative Review.

Michelle M. Nuño, C. Fankhauser, A. Bagrodia, 2022, European urology focus.

Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials.

Michelle M. Nuño, J. Grill, Marina Ritchie, 2022, Journal of Alzheimer's disease : JAD.

On the design of early-phase Alzheimer’s disease clinical trials with cerebrospinal fluid tau outcomes

Michelle M. Nuño, J. Grill, D. Gillen, 2021, Clinical trials.

Robust estimation in the nested case‐control design under a misspecified covariate functional form

Michelle M Nuño, Daniel L Gillen, Michelle M. Nuño, 2020, Statistics in medicine.

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis.

Michelle M. Nuño, A. L. Frazier, N. Coleman, 2021, Clinical genitourinary cancer.

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Michelle M. Nuño, J. Ringman, D. Elashoff, 2017, Alzheimer's Research & Therapy.

Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer’s trials

Michelle M. Nuño, D. Gillen, J. Grill, 2019, Alzheimer's Research & Therapy.

Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?

Michelle M. Nuño, D. Gillen, J. Grill, 2019, Alzheimer disease and associated disorders.

Censoring‐robust time‐dependent receiver operating characteristic curve estimators

Michelle M. Nuño, D. Gillen, 2021, Statistics in medicine.

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate range

Michelle M. Nuño, V. Margulis, N. Coleman, 2023, Research square.

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Michelle M. Nuño, J. Ringman, D. Elashoff, 2017, Alzheimer's Research & Therapy.

Characterizing Lymphovascular Invasion in Pediatric and Adolescent Malignant Ovarian Nongerminomatous Germ Cell Tumors: A Report from the Children’s Oncology Group

Michelle M. Nuño, F. Hazard, A. L. Frazier, 2023, Journal of Pediatric Surgery.

On estimation in the nested case‐control design under nonproportional hazards

Michelle M. Nuño, D. Gillen, 2021, Scandinavian Journal of Statistics.

Refining the serum miR-371a-3p test for viable germ cell tumor detection

Michelle M. Nuño, V. Margulis, A. L. Frazier, 2023, Scientific reports.

Effects of informant replacement in Alzheimer's disease clinical trials

Michelle M. Nuño, J. Grill, D. Gillen, 2023, Alzheimer's & dementia.